Zhi-heng Li

Soochow, 215003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

The RNA polymerase II subunit B (RPB2) functions as a growth regulator in human glioblastoma.

The RNA polymerase II subunit B (RPB2) functions as a growth regulator in human glioblastoma.

Journal: Biochemical and biophysical research communications
Published: May 28, 2023

Long Non-Coding RNA CRNDE Functions as a Tumor Promoter by Modulating the ERK/MAPK Signaling Pathway in Neuroblastoma Cells.

Long Non-Coding RNA CRNDE Functions as a Tumor Promoter by Modulating the ERK/MAPK Signaling Pathway in Neuroblastoma Cells.

Journal: Annals of clinical and laboratory science
Published: December 23, 2022

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma.

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma.

Journal: Journal of immunology research
Published: July 27, 2022

Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.

Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.

Journal: Journal of experimental & clinical cancer research : CR
Published: April 01, 2022

BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma.

BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma.

Journal: Cell & bioscience
Published: December 14, 2021

SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7.

SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7.

Journal: Cell death & disease
Published: October 27, 2021

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1.

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1.

Journal: Cancer cell international
Published: July 27, 2021

MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1.

MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1.

Journal: Oncology letters
Published: May 20, 2021

COCH predicts survival and adjuvant TACE response in patients with HCC.

COCH predicts survival and adjuvant TACE response in patients with HCC.

Journal: Oncology letters
Published: April 16, 2020

Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.

Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.

Journal: Oncology reports
Published: September 01, 2016

Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells.

Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells.

Journal: Cancer cell international
Published: July 29, 2016

A novel sphingosine kinase 1 inhibitor (SKI-5C) induces cell death of Wilms' tumor cells in vitro and in vivo.

A novel sphingosine kinase 1 inhibitor (SKI-5C) induces cell death of Wilms' tumor cells in vitro and in vivo.

Journal: American journal of translational research
Published: July 11, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026